siinfekl peptide OVA G4 peptide is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL - OVApeptide ovalbumin-derived peptide SIINFEKL Unpacking the Significance of the SIINFEKL Peptide in Immunological Research

SIINFEKLantibody The SIINFEKL peptide, a specific octameric sequence derived from chicken ovalbumin (OVA), holds a prominent position in the field of immunology. This ovalbumin-derived peptide SIINFEKL is not just another amino acid chain; it's a crucial tool for understanding and manipulating immune responses, particularly involving T cells. Its well-defined characteristics and predictable interactions with the immune system make it indispensable for a variety of research applications, from basic antigen processing studies to the development of novel vaccines and cancer therapies.Molecular Formula. C45H74N10O ; Synonyms.SIINFEKL; OVA PEPTIDE (257-264); C45H74N10O13; Chicken Ovalbumin Peptide; POV-3659-PI ; Molecular Weight. 963.1 g/mol.

At its core, the SIINFEKL peptide is recognized as a class I (Kb)-restricted peptide epitope of OVA. This means it is presented by the MHC class I molecule, H-2Kb, on the surface of antigen-presenting cells. This presentation is critical for activating cytotoxic T lymphocytes (CTLs), specifically CD8+ T cells, which are key players in eliminating virus-infected cells and cancer cells.OVA 257 264 peptide SIINFEKL - KLH conjugate The sequence itself, SIINFEKL, is an eight-amino acid peptide that has been extensively studied and characterized. Its molecular formula is C45H74N10O13, with a molecular weight of approximately 963SIINFEKL, a potent immunogenic peptide, plays a pivotal role in immunological studies, cancer research, and vaccine development..1 g/mol.

The utility of SIINFEKL stems from its role as an immunodominant epitope. This means it elicits a strong and consistent immune response, making it an ideal candidate for experimental manipulation. Researchers routinely use SIINFEKL to stimulate ovalbumin-specific T cells and to evaluate the efficacy of new vaccine adjuvants. Its predictable interaction with the H-2Kb molecule allows for precise monitoring of antigen presentation and T cell activation. For instance, the 25-D1.16 monoclonal antibody is known to specifically react with the ovalbumin-derived peptide SIINFEKL bound to H-2Kb, providing a means to detect and quantify this specific peptide-MHC complex.SIINFEKL is a peptide derived from ovalbumin (ova) widely utilized in fundamental studies of antigen processing and presentation by antigen-presenting cells ...

Beyond its direct use, variations of the SIINFEKL peptide are also of significant interest.Single peptide (SIINFEKL) for stimulation of mouse Ovalbumin-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I H-2 Kb ... The OVA G4 peptide is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL, offering researchers slightly altered properties for their studies. These variants can be crucial for fine-tuning experimental outcomes or exploring the nuances of T cell receptor recognition.

The applications of SIINFEKL peptide are diverse and impactful. In immunological studies, it serves as a standard model to investigate fundamental processes such as antigen processing and presentation. The SIINFEKL peptide is also instrumental in developing and testing anti-SIINFEKL antibodies, which can be used for various diagnostic and research purposes. Furthermore, its role in T cell activation makes it relevant for cancer research and vaccine development. For example, SIINFEKL, a potent immunogenic peptide, plays a pivotal role in immunological studies, cancer research, and vaccine developmentBiotinylated Mouse H-2Kb&B2M&OVA (SIINFEKL) .... The ability to generate specific immune responses against tumor-associated antigens is a cornerstone of cancer immunotherapy, and SIINFEKL provides a well-understood model system for exploring such strategies.Ova peptide (257-264) | C45H74N10O13 - PubChem - NIH

The synthesis and availability of SIINFEKL peptide are crucial for its widespread useBiotinylated Mouse H-2Kb&B2M&OVA (SIINFEKL) .... Researchers can obtain this peptide in various forms, including as a single peptide (SIINFEKL) for direct stimulation of T cells, or conjugated to carrier proteins like KLH for antibody generation. The purity of these peptides is generally high, often ≥ 95% (UHPLC), ensuring reliable experimental resultsDescription, This is aclass I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.. The OVA 257 264 peptide (SIINFEKL) is readily available from numerous scientific suppliers, often listed under catalog numbers like s7951 or EP01994_1The 25-D1.16 monoclonal antibody reacts with mouse MHC class I H-2Kb bound to the ovalbumin-derivedpeptidewith sequenceSIINFEKL..

Understanding the presentation of SIINFEKL is also key. It has been demonstrated that SIINFEKL is far more efficiently presented when DC are loaded directly with the SIINFEKL-peptide than when the peptide is cross-presented by H-2Kb molecules. This highlights the importance of the delivery method for optimal antigen presentation and subsequent immune activationOVA G4 peptide TFA is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL (257-264).SIINFEKL isroutinely used to stimulate ovalbumin-specific T cells.. Tools like MHC MACSimer H-2Kb Ovalbumin (SIINFEKL), mouse have been developed for the reliable detection, characterization, and isolation of antigen-specific T cells, further underscoring the importance of this peptide in immunological research.

In summary, the SIINFEKL peptide is a foundational element in modern immunologyOVA G4 peptide is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL(257-264). SIINFEKL is routinely used to stimulate ovalbumin-specific T cells and to .... Its precise amino acid sequence, its defined interaction with the H-2Kb MHC class I molecule, and its consistent ability to stimulate ovalbumin-specific CD8+ T cells make it an invaluable tool for research.Ovalbumin peptide SIINFEKL (H-2 Kb) for stimulation ... From elucidating fundamental immune mechanisms to driving the innovation of new therapeutic strategies, the SIINFEKL peptide continues to be a critical component in advancing our understanding of the immune system.